Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Estimation across multiple models with application to Bayesian computing and software development

Stevens RJ, Sweeting TJ

Statistics and Computing 2007;17:245-252. Published:Sep-2007. Epub:27-Jul-2007.

doi:10.1007/s11222-007-9026-y (non-DTU reference)

Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting

The Mount Hood 4 Modeling Group

Diabetes Care 2007;30:1638-1646. Published:Jun-2007.

PMID:17526823doi:10.2337/dc07-9919

Framingham, SCORE, and DECODE risk equations do not provide reliable cardiovascular risk estimates in type 2 diabetes

Ruth L. Coleman, Richard J. Stevens, Ravi Retnakaran, and Rury R. Holman

Diabetes Care 2007;30:1292-1293. Published:May-2007. Epub:08-Feb-2007.

PMID:17290036doi:10.2337/dc06-1358

Non-HDL Cholesterol is less informative than the total-to-HDL cholesterol ratio in predicting cardiovascular risk in type 2 diabetes

Holman RR, Coleman RL, Shine BS, Stevens RJ

Diabetes Care 2005;28:1796-1797. Published:Jul-2005.

PMID:15983339doi:10.2337/diacare.28.7.1796

Framingham risk equations underestimate coronary heart disease risk in diabetes

R. J. Stevens, R. L. Coleman, R. R. Holman

Diab Med. 2005;22:228. Published:Feb-2005. Epub:19-Jan-2005.

PMID:15660747doi:10.1111/j.1464-5491.2005.01387.x

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66

Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR

Diabetes Care 2004;27:201-207. Published:Jan-2004.

PMID:14693990doi:10.2337/diacare.27.1.201 [Abstract]

Evaluation of methods for interval estimation of model outputs, with application to survival models

Stevens RJ

Journal of Applied Statistics 2003;30:967-981. Published:Sep-2003.

doi:10.1080/0266476032000076100

Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine

Kothari V, Stevens RJ, Adler AI, Stratton IM, Manley SE, Neil HA, Holman RR

Stroke 2002;33:1776-1781. Published:Jul-2002.

PMID:12105351doi:10.1161/01.STR.0000020091.07144.C7 [Abstract]

The UKPDS Risk Engine: a model for the risk of coronary heart disease in type 2 diabetes

Richard J. STEVENS, Viti KOTHARI, Amanda I. ADLER, Irene M. STRATTON and Rury R. HOLMAN on behalf of the United Kingdom Prospective Diabetes Study (UKPDS) Group

Clin Sci (Lond). 2001;101:671-679. Published:Dec-2001.

PMID:11724655doi:10.1042/cs1010671 [Abstract]

Conference Abstracts

American Diabetes Association (ADA) Conference, Philadelphia

Updated UKPDS Risk Engine that Estimates Primary and Secondary Cardiovascular Disease Risk in People With Recently-Diagnosed or Established Type 2 Diabetes

Coleman RL, Stevens RJ, Holman RR

Diabetes 2012;61:Supp 1:A103

[Abstract]

67th Scientific Session of the American Diabetes Association, Chicago

The Oxford Risk Engine: A Cardiovascular Risk Calculator for Individuals with or without Type 2 diabetes

Coleman RL, Stevens RJ, Holman RR

Diabetes 2007;56:Suppl 1:A170

[Abstract]

The Diabetes UK Annual Professional Conference, Glasgow

Estimating cardiovascular disease risk for individuals with Type 2 diabetes: the new UKPDS Risk Engine

Coleman RL, Stevens RJ, Holman RR

Diabetic Medicine 2007;24:Suppl 1:56

[Abstract]

43rd Annual Meeting of the European Association for the Study of Diabetes, Amsterdam

Are measures of adiposity associated independently with incident cardiovascular disease in individuals with newly diagnosed type 2 diabetes?

Coleman RL, Holman RR

Diabetologia 2007;50:Suppl 1:S502

[Abstract]

Diabetes UK Annual Professional Conference, Birmingham

Estimating risk of clinically evident neuropathy in type 2 diabetes: a UKPDS risk equation

Coleman RL, Stevens RJ, Holman RR

Diabetic Medicine 2006;23:Suppl. 2:51

66th Scientific Session of the American Diabetes Association, Washington

Estimating Risk of Clinically Evident Retinopathy in Type 2 Diabetes.

Coleman RL, Stevens RJ, Aldington SJ, Holman RR

Diabetes 2006;55:Suppl 1:A53

65th Scientific Sessions of the American Diabetes Association, San Diego

A Cardiovascular Risk Calculator for Type 2 Diabetes

Coleman RL, Stevens RJ, Matthews DR, Holman R

Diabetes 2005;54:Suppl 1:A172

41st Annual Meeting of the European Association for the Study of Diabetes, Athens

Incident nephropathy in type 2 diabetes: a UKPDS Risk Equation

Coleman RL, Stevens RJ, Holman RR

Diabetologia 2005;48:Suppl 1:A32

40th Annual Meeting of the European Association for the Study of Diabetes, Munich

Risk factors for neuropathy in UKPDS

Stratton IM, Holman RR, Boulton AJM

Diabetologia 2004;47:Suppl 1:A47

[Abstract]

63rd Scientific Sessions of the American Diabetes Association, New Orleans

Risk of Heart Failure in Type 2 Diabetes

Coleman R, Stevens RJ, Stratton IM, Adler A, Matthews D, Holman RR

Diabetes 2003;52:Suppl 1:A217

62nd Scientific Sessions of the American Diabetes Association, San Francisco

Forecasting Coronary Case Fatality in Type 2 Diabetes: A UKPDS Risk Engine Equation

Stevens RJ, Coleman RL, Adler AI, Stratton IM, Holman RR

Diabetes 2002;51:Suppl 2:A172